Quantcast

Latest Insulin therapy Stories

2014-06-10 08:31:09

JERUSALEM, June 10, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. [http://oramed.com ] (NASDAQCM: ORMP) ( http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that three scientific abstracts summarizing studies performed with ORMD-0801, its orally ingestible insulin capsule, were accepted for inclusion at the American Diabetes Association 74th Scientific Sessions, which will take place in...

2014-06-09 08:29:57

· Data for investigational compounds LY2963016, empagliflozin and empagliflozin/linagliptin combination tablet highlight robust alliance pipeline RIDGEFIELD, Conn. and INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- More than 40 posters, abstracts and oral presentations will demonstrate the breadth and depth of the Boehringer Ingelheim (BI) and Eli Lilly and Company (NYSE: LLY) diabetes portfolio at the 74(th) American Diabetes Association (ADA) Scientific Sessions® in San Francisco, June 13-17....

2014-06-04 08:33:25

MONTREAL, June 4, 2014 /CNW Telbec/ - A Canadian study has identified a new strategy for improving the care of patients living with Type 2 Diabetes (T2D) by empowering them to manage their own insulin therapy. The START study (Self-Titration with Apidra® to Reach Target)(1), the first research of its kind, found that T2D patients adjusting their own insulin doses can control the disease and achieve blood sugar targets just as safely and effectively as patients whose treatment is...

2014-05-31 23:04:47

Market Size - $4.9 bn in 2013, Market Growth - CAGR of 17.6%, Market Trends – Substitution of human insulin by analogs new report by Grand View Research. View complete report with TOC - http://www.grandviewresearch.com/industry-analysis/asia-pacific-insulin-market. San Francisco, California (PRWEB) May 31, 2014 The Asia Pacific market for Insulin is expected to reach USD 15.04 billion by 2020, according to a new study by Grand View Research, Inc. Growing regional prevalence of diabetes,...

2014-05-21 08:29:48

DUBLIN, May 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vzwl7f/insulin_pumps) has announced the addition of the "Insulin Pumps (External) - Global Strategic Business Report" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

2014-05-17 08:20:13

Panel discussion addresses nephrolithiasis ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- Two studies examining the influences and impacts of kidney stones, show ultrasound reduces radiation exposure and is less expensive compared to computed tomography (CT) scans, while a second study indicates better glycemic control in diabetic patients lowers the risk for kidney stone development. Both studies will be presented at the 109(th) Annual Scientific Meeting of the American Urological...

diabetes two meals per day
2014-05-17 06:15:29

April Flowers for redOrbit.com - Your Universe Online The prevailing wisdom for those with Type 2 diabetes is to eat three to six small meals a day in order to keep blood glucose (BG) levels even, instead of spiking as it does with fewer, or more irregular, meals. A new study from the Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, however, reveals that two large meals – breakfast and lunch (with the same calorie count as the six smaller meals)...

2014-05-15 16:27:59

--- Data Presented at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress --- BRIDGEWATER, N.J., May 15, 2014 /PRNewswire/ -- Valeritas, makers of the V-Go® Disposable Insulin Delivery Device, announced interim analysis data from SIMPLE, a prospective observational study, today that suggest patients with Type 2 diabetes who switched to V-Go therapy from their previous baseline treatment of long-acting insulin with or without oral...

2014-05-12 08:32:58

Lilly expects U.S. and European regulatory submissions by Q1 2015 INDIANAPOLIS, May 12, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of three completed Phase III clinical trials in patients with type 2 diabetes for basal insulin peglispro (BIL), which is being studied as a once-daily treatment for both type 1 and type 2 diabetes. The primary efficacy endpoint of non-inferior reduction in hemoglobin A1c (HbA1c) compared to insulin...

2014-05-01 23:03:44

Most health plans consider insulin pump therapy medically necessary when patients meet very specific criteria. Despite the increased use of insulin pump therapy based on recommendations made by the American Association of Diabetes Educators, the American Association of Clinical Endocrinologists, and the American Diabetes Association, there is no official guideline for the initiation of insulin pump use. (PRWEB) May 01, 2014 Technological advances continue to increase the appeal of insulin...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.